Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Pranlukast in seasonal allergic rhinitis
NCT00127647Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2004
- Primary completion
- Apr 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of montelukast in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Organon & Co. Primary endpoint: Composite Nasal Symptom Score at 2 weeks. Started Nov 2004; status: completed.
02
Drugs
montelukast
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00127647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00127647.